Results 291 to 300 of about 495,743 (373)

Management of Retropharyngeal Lymph Node Metastases in Thyroid Cancer

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Retropharyngeal lymph node (RPLN) metastases in thyroid cancer are rare, with optimal management underreported. Methods Retrospective study of consecutive thyroid cancer patients with RPLN metastases treated at MD Anderson Cancer Center between 2000 and 2024.
Isabelle Fournier   +19 more
wiley   +1 more source

Microtracer-Based Assessment of the Mass Balance, Pharmacokinetics, and Excretion of [<sup>14</sup>C]Berzosertib, an Intravenous ATR Inhibitor, in Patients With Advanced Solid Tumors: A Phase 1 Study. [PDF]

open access: yesClin Pharmacol Drug Dev
Bolleddula J   +12 more
europepmc   +1 more source

Segmental Tracheal Resection for Thyroid Cancer: Perioperative Morbidity, Locoregional Control, and Survival

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Segmental tracheal resection is rarely needed for advanced thyroid cancer but is among the most complex, high‐risk thyroid surgeries. Methods Retrospective study of patients undergoing segmental tracheal resection for thyroid cancer at MD Anderson Cancer Center (2005–2024).
Anastasios Maniakas   +19 more
wiley   +1 more source

Mortality from cancer and non‐cancer diseases in the Lithuanian cohort of Chernobyl cleanup workers (2001–2020)

open access: yesInternational Journal of Cancer, EarlyView.
What's New? Following the Chernobyl disaster, workers were recruited from formerly Soviet‐occupied areas, including Lithuania, to participate in clean‐up efforts. Radiation exposure incurred by workers during these efforts offers a unique opportunity for the study of long‐term health effects.
Rita Steponaviciene   +3 more
wiley   +1 more source

Rapid cleavage of 6-[<sup>18</sup>F]fluoronicotinic acid prosthetic group governs BT12 glioblastoma xenograft uptake: implications for radiolabeling design of biomolecules. [PDF]

open access: yesEJNMMI Radiopharm Chem
Dillemuth P   +15 more
europepmc   +1 more source

Neoadjuvant endocrine therapy often leads to breast and axilla‐conserving surgery in stages II and III hormone receptor‐positive breast cancer patients: A registry study

open access: yesInternational Journal of Cancer, EarlyView.
What's New? This study evaluated patient characteristics and treatment strategies in stages II and III HR+/HER2− breast cancer. Neoadjuvant systemic therapy frequently facilitated breast‐conserving procedures and less invasive axillary surgery. Approximately half of the patients undergoing primary surgery received a mastectomy, and all with positive ...
Layla Andour   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy